Search research articles
Contact Us
Filters
Showing results (811-820 of 920) with videos related to
Page
of 92
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2017
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma
Yun-Fan Sun, Wei Guo, Yang Xu, et al.
Nature Communications
|
January 13, 2026
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)
Anna Li, Wei-Neng Feng, Juan Li, et al.
Frontiers in Oncology
|
September 10, 2021
Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa Trial
Lili Mao, Ya Ding, Xue Bai, et al.
Cell Death & Disease
|
October 23, 2020
BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity
Wen-Jing Yang, Yun-Fan Sun, An-Li Jin, et al.
The Lancet. Gastroenterology & Hepatology
|
April 13, 2019
Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study
Milan J Sonneveld, Willem P Brouwer, Henry L-Y Chan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 9, 2020
Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial
Yun Fan, Jun Zhao, Qiming Wang, et al.
Plos One
|
July 18, 2018
No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B
Lai Wei, Heiner Wedemeyer, Yun-Fan Liaw, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
Proline transporters balance the salicylic acid-mediated trade-off between regeneration and immunity in plants
Dawei Xu, Zeinu Mussa Belew, Nathália Cássia Ferreira Dias, et al.
Signal Transduction and Targeted Therapy
|
January 3, 2023
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results
Chuan Qin, Dai-Shi Tian, Luo-Qi Zhou, et al.
BMC Cancer
|
May 11, 2018
PDXliver: a database of liver cancer patient derived xenograft mouse models
Sheng He, Bo Hu, Chao Li, et al.
Page
of 92
Search research articles
Search
Showing results (811-820 of 920) with videos related to
Sort By:
Page
of 92
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2017
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma
Yun-Fan Sun, Wei Guo, Yang Xu, et al.
Nature Communications
|
January 13, 2026
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)
Anna Li, Wei-Neng Feng, Juan Li, et al.
Frontiers in Oncology
|
September 10, 2021
Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa Trial
Lili Mao, Ya Ding, Xue Bai, et al.
Cell Death & Disease
|
October 23, 2020
BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity
Wen-Jing Yang, Yun-Fan Sun, An-Li Jin, et al.
The Lancet. Gastroenterology & Hepatology
|
April 13, 2019
Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study
Milan J Sonneveld, Willem P Brouwer, Henry L-Y Chan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 9, 2020
Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial
Yun Fan, Jun Zhao, Qiming Wang, et al.
Plos One
|
July 18, 2018
No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B
Lai Wei, Heiner Wedemeyer, Yun-Fan Liaw, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
Proline transporters balance the salicylic acid-mediated trade-off between regeneration and immunity in plants
Dawei Xu, Zeinu Mussa Belew, Nathália Cássia Ferreira Dias, et al.
Signal Transduction and Targeted Therapy
|
January 3, 2023
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results
Chuan Qin, Dai-Shi Tian, Luo-Qi Zhou, et al.
BMC Cancer
|
May 11, 2018
PDXliver: a database of liver cancer patient derived xenograft mouse models
Sheng He, Bo Hu, Chao Li, et al.
Page
of 92